What committees review the use of radioactive materials in human research?
There are three regulatory committees at UCSF for the review of research using radioactive materials in human subjects. First, the Committee on Human Research (CHR) reviews all research involving human subjects. In addition to CHR approval, your research must also be reviewed for approval by one of two following committees. If the human research is for the diagnosis or treatment of disease in patients and involves exposure to radioisotopes or ionizing radiation other than the exposure inherent in standard care, the Radiation Safety Committee must also review your proposal. If the research uses a radioisotope in human subjects to study pharmacokinetics or basic physiology (as opposed to using a radioisotope to treat or diagnose disease), then the Radioactive Drug Research Committee (RDRC) must also review the research.
